Establishment Labs Holdings Inc

ESTANASDAQ · USD
69.14USD0.00 (-0.68%)
327

Establishment Labs Holdings Inc (ESTA) Covered Calls

Establishment Labs Holdings Inc trades in the Medical Devices industry with an IV Rank of 26.19%, low versus the past year. ESTA's highest covered call setup is the $85.00 strike expiring Dec 18, 2026, sorted by theoretical annualized return. It's 22.28% out of the money with 31 days to expiration, a 22.57% return until expiration, and a 265.77% theoretical annualized return. Across the setups shown, annualized returns run from 111.63% to 265.77% at strikes between $70.00 and $95.00, with 3 to 94 days to expiration, as of Nov 17, 2026.

Read more

Running ESTA covered calls helps you generate income from Establishment Labs Holdings Inc shares you already own, turning a long stock position into a yield producing asset. A covered call means holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike. Use our scanner to find the best ESTA covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call pairs limited risk with a clear income profile. If ESTA stays below the strike at expiration, you keep the premium and the shares. If it rises above, you deliver the stock at the strike and still pocket the premium. Selling ESTA covered calls works best when implied volatility is elevated, since richer premiums improve the risk reward. Key inputs include strike selection relative to delta, days to expiration, annualized return, and probability of assignment, all of which determine whether a given ESTA covered call is worth writing.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally.

2026-12-183185.0022.280.203.001569.0022.57265.77-0.29+0.21132.80
2026-11-20370.000.700.904.80139.002.00243.30-1.29+0.50213.90
2026-12-183182.5018.690.303.701329.0019.12225.12-0.43+0.2513.40
2026-12-183180.0015.090.204.901069.0015.38181.08-0.29+0.30244.70
2026-12-183177.5011.490.654.60864.0012.43146.35-0.94+0.33123.95
2027-02-199495.0036.670.653.702614.0037.61146.02-0.94+0.21143.05
2027-01-155985.0022.280.454.401594.0022.93141.87-0.65+0.2603.95
2027-02-199492.5033.070.854.102384.0034.30133.18-1.22+0.23213.25
2027-02-199490.0029.480.704.102119.0030.48118.37-1.01+0.2433.40
2026-12-183175.007.901.105.00659.009.48111.63-1.58+0.38443.90

As of Nov 17, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV Rank26.19% Low
  • Market cap (M$)2,062
  • 52 weeks high-29.15%
  • 52 weeks low30.06%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$98.00
    41.74% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-10-29
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.28
  • EPS growth next 5 years—

As of Nov 20, 2026